|
Real-time Estimate
Cboe BZX
13:44:27 2026-10-08 EDT
|
5-day change | 1st Jan Change | ||
| 20.52 USD | +1.38% |
|
+1.09% | -11.13% |
| 09-20 | Damora Therapeutics, Inc.(NasdaqCM:DMRA) added to S&P Global BMI Index | CI |
| 08-10 | Damora Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.38% | +1.09% | -29.89% | -25.72% | -11.13% | +92.02% | +28.82% | -75.80% | - | 1.25B | |
| -3.19% | -3.19% | +5.71% | +36.94% | +78.73% | +44.60% | +87.98% | +6.02% | - | 74.68B | |
| -15.86% | -16.16% | -18.50% | -11.78% | -1.56% | +2.68% | +51.09% | +176.38% | +4,700.00% | 58.7B | |
| -2.39% | +0.50% | +1.33% | -1.68% | +4.76% | +3.41% | +31.33% | -18.54% | +202.09% | 48.36B | |
| -8.11% | -9.67% | -10.29% | -1.99% | +133.50% | +288.93% | +630.21% | +569.49% | - | 43.05B | |
| -0.55% | -1.99% | -1.42% | +25.39% | +13.36% | +27.38% | +28.06% | +5.49% | +220.18% | 42.48B | |
| -4.63% | -3.38% | -1.37% | +14.83% | +14.10% | -1.26% | +100.63% | -4.56% | +979.60% | 41.39B | |
| -2.13% | +1.07% | -3.60% | +0.79% | +4.19% | +7.51% | +50.31% | +2.56% | +139.76% | 31.29B | |
| -2.61% | -4.08% | -5.84% | -0.67% | -2.42% | -12.59% | -15.01% | -62.23% | - | 23.93B | |
| -2.43% | -9.06% | -20.93% | -15.26% | -43.26% | -38.97% | +302.90% | +246.98% | +557.02% | 22.22B | |
| -5.27% | +1.86% | +8.82% | +24.52% | +16.23% | +12.19% | -3.32% | -15.04% | +105.41% | 22.24B | |
| -1.28% | -0.45% | +0.76% | +11.91% | +6.00% | +12.12% | +140.11% | +215.34% | +1,868.13% | 16.87B | |
| -0.83% | -1.65% | -9.81% | -11.33% | +182.04% | +139.28% | +356.14% | +1,992.52% | +684.56% | 15.67B | |
| -1.07% | +1.56% | +6.32% | +12.88% | +21.31% | +21.51% | +45.47% | -28.45% | +83.09% | 14.87B | |
| -1.40% | -1.28% | -16.91% | -19.04% | - | - | - | - | - | 15B | |
| -3.26% | +1.31% | +3.50% | +29.76% | +45.68% | +67.52% | +50.52% | -28.98% | +248.11% | 14.34B | |
| +2.40% | +3.30% | +3.78% | +6.67% | +36.55% | +54.89% | +178.50% | +176.83% | +374.62% | 14.48B | |
| -4.46% | +3.11% | -0.41% | +9.68% | -1.61% | -26.27% | +930.46% | +245.55% | +44.85% | 14.36B | |
| -3.84% | -12.13% | +4.56% | +17.37% | +13.84% | -34.90% | - | - | - | 12.69B | |
| -0.77% | -0.06% | +2.16% | -2.24% | -11.23% | -13.26% | -32.19% | -39.02% | +104.71% | 12.66B | |
| Average | -3.03% | -1.52% | -4.10% | +5.05% | +26.27% | +34.04% | +164.55% | +186.92% | +736.58% | 27.03B | |
| Weighted average by Cap. | -4.40% | -1.26% | -3.39% | +8.44% | +32.05% | +38.32% | +148.90% | +151.56% | +1,105.81% |
- Stock Market
- Stocks
- DMRA Stock
- Sector Damora Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
